AgeX Therapeutics Inc. (NYSEAMERICAN:AGE) and Harpoon Therapeutics Inc. (NASDAQ:HARP) compete with each other in the Biotechnology sector. We will analyze and compare their analyst recommendations, institutional ownership, profitability, risk, dividends, earnings and valuation.

Valuation and Earnings

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
AgeX Therapeutics Inc.	1.40M	106.51	7.50M	-0.16	0.00
Harpoon Therapeutics Inc.	4.75M	57.13	27.37M	-0.94	0.00

Table 1 showcases the top-line revenue, earnings per share (EPS) and valuation of AgeX Therapeutics Inc. and Harpoon Therapeutics Inc.

Profitability

Table 2 has AgeX Therapeutics Inc. and Harpoon Therapeutics Inc.’s return on equity, net margins and return on assets.

	Net Margins	Return on Equity	Return on Assets
AgeX Therapeutics Inc.	-535.71%	0%	0%
Harpoon Therapeutics Inc.	-576.21%	0%	0%

Liquidity

AgeX Therapeutics Inc.’s Current Ratio is 6.5 while its Quick Ratio is 6.5. On the competitive side is, Harpoon Therapeutics Inc. which has a 3.8 Current Ratio and a 3.8 Quick Ratio. AgeX Therapeutics Inc. is better positioned to pay off short and long-term obligations compared to Harpoon Therapeutics Inc.

Analyst Recommendations

The table delivered features the ratings and recommendations for AgeX Therapeutics Inc. and Harpoon Therapeutics Inc.

	Sell Ratings	Hold Ratings	Buy Ratings	Rating Score
AgeX Therapeutics Inc.	0	0	0	0.00
Harpoon Therapeutics Inc.	0	0	2	3.00

Meanwhile, Harpoon Therapeutics Inc.’s consensus target price is $23.5, while its potential upside is 110.76%.

Institutional and Insider Ownership

Roughly 17.3% of AgeX Therapeutics Inc. shares are held by institutional investors while 35.2% of Harpoon Therapeutics Inc. are owned by institutional investors. About 45.9% of AgeX Therapeutics Inc.’s share are held by insiders. Competitively, Harpoon Therapeutics Inc. has 0.5% of it’s share held by insiders.

Performance

Here are the Weekly, Monthly, Quarterly, Half Yearly, Yearly and YTD Performance of both pretenders.

	Performance (W)	Performance (M)	Performance (Q)	Performance (HY)	Performance (Y)	Performance (YTD)
AgeX Therapeutics Inc.	-14.43%	7.24%	0%	0%	0%	38.8%
Harpoon Therapeutics Inc.	18.45%	0%	0%	0%	0%	26%

For the past year AgeX Therapeutics Inc.’s stock price has bigger growth than Harpoon Therapeutics Inc.

Summary

AgeX Therapeutics Inc. beats on 7 of the 9 factors Harpoon Therapeutics Inc.